Insider Trading February 13, 2026

Itron HR Executive Sells Shares to Cover Tax Withholding as Stock Trades Near 52-Week Low

Laurie Ann Pulatie-Hahn disposed of 142 ITRI shares on Feb. 11; company navigates analyst downgrade and expanding utility partnerships ahead of earnings

By Marcus Reed ITRI
Itron HR Executive Sells Shares to Cover Tax Withholding as Stock Trades Near 52-Week Low
ITRI

Laurie Ann Pulatie-Hahn, Itron's senior vice president of human resources, sold 142 shares of Itron, Inc. (NASDAQ: ITRI) on February 11, 2026, in a transaction disclosed on a Form 4 filing. The shares were sold at $105.2648 apiece for $14,947, and the sale was made to satisfy tax withholding related to vesting restricted stock units. The trade comes as Itron's share price has fallen close to its 52-week low and the company faces a recent analyst downgrade even as it expands partnerships with utilities and technology providers.

Key Points

  • Laurie Ann Pulatie-Hahn sold 142 shares of Itron on Feb. 11, 2026 at $105.2648 per share to cover tax withholding on vested restricted stock units.
  • After the sale Pulatie-Hahn directly owns 21,783 shares; Itron is valued at $4.13 billion and its stock is trading near a 52-week low.
  • Itron faces a recent downgrade from Guggenheim and lowered revenue and EBITDA expectations even as it expands partnerships with PG&E, Microsoft, and Tucson Water.

Transaction details

According to a Form 4 filed with the Securities and Exchange Commission, Laurie Ann Pulatie-Hahn, Itron, Inc.'s senior vice president of human resources, sold 142 shares of common stock on February 11, 2026. The shares were sold at $105.2648 per share, producing a total transaction value of $14,947. The filing states the sale was executed to satisfy tax withholding obligations tied to the vesting of a restricted stock unit award.

Holdings after the sale

Following the transaction, Pulatie-Hahn is reported to directly own 21,783 shares of Itron, Inc. The company is described in the filing as having a market valuation of $4.13 billion.

Market context

Itron's shares are trading at $92.34 and, according to InvestingPro data cited in the filing, the stock has fallen nearly 8% over the past week and is trading near its 52-week low of $90.11. Investors are approaching the company's scheduled earnings report on February 17 with these price movements and insider activity noted.

Valuation and analyst views

InvestingPro analysis referenced in the filing indicates that Itron is trading below its Fair Value and highlights a free cash flow yield of 8% for the company. Separately, Guggenheim recently downgraded Itron from a Buy rating to Neutral, citing concerns about the company's growth trajectory. Guggenheim revised its revenue forecasts to $2.32 billion for 2026 and $2.42 billion for 2027 and also implemented sizable reductions in its EBITDA expectations for the company.

Business developments

While managing near-term market pressure, Itron continues to advance commercial initiatives. The company and Pacific Gas & Electric are broadening their collaboration to improve grid safety and encourage electric vehicle adoption by integrating Itron's Grid Edge Intelligence solutions to enhance grid reliability and reduce wildfire risks. In addition, Itron is expanding its relationship with Microsoft by rolling out a new intelligent edge connector - the Intelligent Edge Operating System (IEOS) Connector for Microsoft 365 Copilot - designed to let utility workers query consumption and operational data using natural language.

On the water utility front, Tucson Water is implementing Itron's Advanced Metering Infrastructure Essentials to support conservation and operational efficiency, with plans to deploy 250,000 smart water communication modules by 2029.

Broader coverage

The filing also references InvestingPro's broader research coverage, noting a Pro Research Report and a universe of more than 1,400 U.S. equities that are covered in depth on the platform.


This article reports the details contained in the SEC filing and related disclosures. It does not add information beyond those disclosures and referenced analyses.

Risks

  • Share price volatility - Itron's stock has declined nearly 8% over the past week and is trading close to its 52-week low, posing market risk to equity holders.
  • Analyst downgrades and downward revisions - Guggenheim reduced Itron's rating to Neutral and lowered revenue and EBITDA forecasts, introducing uncertainty around growth expectations.
  • Earnings period uncertainty - With an earnings report scheduled for February 17, investors face the risk of additional near-term share-price movement based on reported results.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026